New Enterprise Associates related stories
All articles and analysis
Alsop Louie out for second fundStealthy early stage investor is seeking $75M to $100M
- Exit watch, week of Feb. 23, 2009
News briefs about Ventor, Applimation, Chomp and other VC-backed companies that were bought in the past week
- Week in deals, Feb. 16, 2009
Summary of tech companies and other businesses that raised financing in North America in the past week
- SolFocus ups round
Solar energy company on course to raise between $60M and $70M
- PEHUB Wire: Tuesday, February 10, 2009
Random Ramblings
- PEHUB Wire: Tuesday, February 10, 2009
Random Ramblings
- VC Deal Scoop: SolFocus, WhistleBox & More...
What follows are ten VC deals culled from recent Regulation D filings with the SEC. They have not been otherwise disclosed: * SolFocus Inc., a Palo Alto, Calif.-based developer of solar concentrator photovoltaic systems, has raised $19.28 million in additional Series C funding, according to a regulatory filing. The round total is now $66.78 million, from firms like Apex Venture Partners, New Enterprise Associates and NGEN Partners. It is unclear if additional capital will be raised, or if the round is closed (it had been targeting between $60m and $70m). SolFocus previously raised nearly $100 million in its Series A and Series B rounds. www.solfocus.com http://www.solfocus.com * diaDexus Inc., a South San Francisco-based developer of a blood test for the prediction of cardiovascular disease, has raised around $9.2 million in Series F funding, according to a regulatory filing. Listed shareholders include Scale Venture Partners, GlaxoSmithKline
- VC Deal Scoop: SolFocus, WhistleBox & More...
What follows are ten VC deals culled from recent Regulation D filings with the SEC. They have not been otherwise disclosed: * SolFocus Inc., a Palo Alto, Calif.-based developer of solar concentrator photovoltaic systems, has raised $19.28 million in additional Series C funding, according to a regulatory filing. The round total is now $66.78 million, from firms like Apex Venture Partners, New Enterprise Associates and NGEN Partners. It is unclear if additional capital will be raised, or if the round is closed (it had been targeting between $60m and $70m). SolFocus previously raised nearly $100 million in its Series A and Series B rounds. www.solfocus.com http://www.solfocus.com * diaDexus Inc., a South San Francisco-based developer of a blood test for the prediction of cardiovascular disease, has raised around $9.2 million in Series F funding, according to a regulatory filing. Listed shareholders include Scale Venture Partners, GlaxoSmithKline